Company Executives

$CBIO Management Team

Mr. Bruce Johnson

Senior Vice President

Chief Commercial Officer

Age 57

Compensation -

Sex Male

Mr. Chinmaya Rath

Senior Vice President

Chief Business Officer

Age 49

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex	Social Media
Mr. Bruce Johnson Senior Vice President Chief Commercial Officer	57	-	Male
Mr. Chinmaya Rath Senior Vice President Chief Business Officer	49	-	Male

Board of Directors

From the proxy statement filed Apr 21, 2026

Directors

serving now

Independent

4 of 6

stated in the proxy

Average tenure

1.7 years

from year joined

CEO also chairs the board

Peter Harwin

Director	Age	On board	Independent	Committees	Other public boards	Pay
Susan Moran	56	2024 2 years	Independent	Audit Committee	Tyra Biosciences, Inc., BioAtla, Inc.	Not stated
Jonathan Violin	50	2024 2 years	Not independent	Nominating and Corporate Governance Committee	Dianthus Therapeutics, Inc.	Not stated
Joshua Brumm CEO	48	2025 1 year	Not independent	None stated	None stated	Paid as CEO
Peter Harwin Board chair	40	2024 2 years	Independent	None stated	Cogent Biosciences, Inc., Apogee Therapeutics, Inc., Damora Therapeutics, Inc., Oruka Therapeutics, Inc., Spyre Therapeutics, Inc.	$151,575
Alexandra Balcom	42	2024 2 years	Independent	Audit Committee · Chair	None stated	$140,466
David Lubner	62	2025 1 year	Independent	None stated	Arcellx Inc., Dyne Therapeutics, Inc.	$294,991

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 21, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments